Coherus Oncology Inc (CHRS)

Gross Margin

63.55%

TTM · Period ending:

CHRS logo

CHRS Gross Margin

Latest reported63.55%
CHRS TTM Gross Margin (-1037.00% → 63.55%)
High-resolution chart · PNG

CHRS gross margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Coherus Oncology Inc Gross Margin — Trailing twelve months (TTM)
Period endingGross Margin
63.5523%
60.041%
57.9389%
44.1712%
56.0772%
55.5166%
55.4679%
40.6311%
36.4707%
36.7913%
38.1941%
58.011%
49.8934%
57.6867%
66.7919%
71.5617%
80.4335%
80.4204%
82.3639%
84.2794%
88.6278%
91.3429%
92.0838%
93.0918%
93.5892%
95.0114%
95.2038%
84.5247%
52.5184%
-124.1307%
-9,377.491%
-10,216.9023%
-7,758.7917%
-27.4294%
-36.5324%
-33.8411%
-23.5742%
-471.1682%
-560.0875%
-607.9658%
-615.7351%
-294.0093%
-202.386%
-151.4756%
-134.3935%
-356.5201%
-525.9031%
-1,037.0047%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.